Treatment
>
Cabergoline
Pituitary Adenoma
Bolko P
, Jaskula M, Wasko R, Wolun M, Sowinski J
The assessment of cabergoline efficacy and tolerability in patients with pituitary prolactinoma type
Pol Arch Med Wewn. 2003 May;109(5):489-95.
(Clinical Study, Abstract)
HOME
|
Detection
|
Diagnosis
|
Epidemiology
|
Etiology & Pathogenesis
|
Integrative Medicine
|
Overall Mngt & Case Reports
|
Prevention
|
Prognosis
|
Psychosocial Aspects
|
Treatment
About BrainLife
|
Children's Corner
|
E-mail Alerts
|
Journals
|
Newsletter
|
Patients & Caregivers
|
Search
|
Stem Cells
|
WHO Classification
|
SITEMAP
